Abstract

Acute kidney injury (AKI) is a common accompaniment in patients with liver disease. The causes, risk factors, manifestations and management of AKI in these patients vary according to the liver disease in question (acute liver failure, acute-on-chronic liver failure, post-liver transplantation or metabolic liver disease). There are multiple causes of AKI in patients with liver disease—pre-renal, acute tubular necrosis, post-renal, drug-induced renal failure and hepatorenal syndrome (HRS). Definitions of AKI in liver failure are periodically revised and updated, but pediatric definitions have still to see the light of the day. As our understanding of the pathophysiology of liver disease and renal involvement improves, treatment modalities have become more advanced and rationalized. Treatment includes reversing precipitating factors, such as infections and gastrointestinal bleeding, volume expansion, paracentesis and vasoconstrictors. This approach is tried and tested in adults. A pediatric tailored approach is still lacking due to inadequate numbers of patients, differences in causes of AKI and paucity of literature. In this review, we attempt to explore the pathophysiological basis, treatment modalities and controversies in the diagnosis and treatment of AKI in pediatric patients with chronic liver disease and discuss our own personal practice. We recognize that, although it is not a very commonly encountered entity in pediatric population, HRS has specific diagnostic criteria and treatment modalities that differ from other causes of AKI in patients with chronic liver disease; hence among the etiologies of kidney injury in patients with chronic liver disease, we focus here on HRS.

Highlights

  • The association between liver disease and renal failure has been known for over a century

  • We explore some of these issues and current dilemmas in the diagnosis and management of acute kidney injury (AKI) in liver failure, especially in patients with chronic liver disease

  • Though AKI is common in cirrhotic patients with ascites, not all patients of cirrhosis who develop AKI have hepatorenal syndrome (HRS)

Read more

Summary

Introduction

The association between liver disease and renal failure has been known for over a century. NSAIDs, Nonsteroidal anti-inflammatory drugs; NGAL, neutrophil gelatinase associated lipocalin; KIM1, kidney injury molecule 1; IL, interleukin; FABP, liver-type fatty acid-binding protein; ATN, acute tubular necrosis; RBCs,:red blood cells; HRS, hepato-renal syndrome; AKI, acute kidney injury; ICA, International Club of Ascites of patients who undergo Kasai surgery will need a liver transplant [44]. These children are kept under close follow-up. A cystatin C level of > 1.23 mg/L is thought to be better at predicting AKI than SCr

Prophylactic antibiotics
Nephrotoxic drugs
Maintain intravascular volume
Paracentesis
Conclusion
Findings
Compliance with ethical standards
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call